AI assistant
Actinium Pharmaceuticals, Inc. — Director's Dealing 2015
May 9, 2015
34570_dirs_2015-05-08_0bc4c985-a84b-40cb-a381-25c6c0a25489.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Actinium Pharmaceuticals, Inc. (ATNM)
CIK: 0001388320
Period of Report: 2015-05-06
Reporting Person: Memorial Sloan-Kettering Cancer Center (10% Owner)
Reporting Person: AHLB Holdings, LLC (10% Owner)
Reporting Person: Actinium Holdings, Ltd. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-06 | Common Stock | J | 5702387 | — | Acquired | 5702387 | Direct |
Footnotes
F1: Represents a transfer of shares previously held directly by Actinium Holdings Ltd. ("AHL") to Memorial Sloan-Kettering Cancer Center ("MSKCC"). MSKCC owns all of the membership interests in AHLB Holdings, LLC ("AHLB"), which owns all of the outstanding shares of AHL. As a result of the transfer, AHL and AHLB are no longer deemed a beneficial owner of the shares. With respect to MSKCC, the transfer constitutes a change in the form of beneficial interest from indirect to direct in accordance with Rule 16a-13.